Literature DB >> 19275889

Influenza A virus induces p53 accumulation in a biphasic pattern.

Yang Shen1, Xiaodu Wang, Lin Guo, Yafeng Qiu, Xiangdong Li, Hai Yu, Hua Xiang, Guangzhi Tong, Zhiyong Ma.   

Abstract

Tumor suppressor p53, the major cellular defense against tumor development, has recently been implicated in host antiviral defense. Previous studies have shown that p53 was induced at the apoptotic stage of influenza virus-infected cells. However, we found that p53 was induced not only at the apoptotic stage but also at the beginning phase of infection, showing a biphasic pattern with a first transient elevation apparent at the beginning phase of infection and a second elevation observable at the middle-late phase of infection. This up-regulation of p53 was independent of increased p53 transcription, but dependent on virus adsorption and replication. The increased p53 was active and able to transactivate its downstream target genes, such as interferon regulatory factor 9 (IRF9) and Bax. To our knowledge, this is the first report to describe a biphasic pattern of p53 accumulation in influenza virus-infected cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19275889     DOI: 10.1016/j.bbrc.2009.03.018

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Influenza A viruses control expression of proviral human p53 isoforms p53β and Delta133p53α.

Authors:  Olivier Terrier; Virginie Marcel; Gaëlle Cartet; David P Lane; Bruno Lina; Manuel Rosa-Calatrava; Jean-Christophe Bourdon
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

2.  The BM2 protein of influenza B virus interacts with p53 and inhibits its transcriptional and apoptotic activities.

Authors:  H Zhang; H Yu; J Wang; M Zhang; X Wang; W Ahmad; M Duan; Z Guan
Journal:  Mol Cell Biochem       Date:  2015-02-11       Impact factor: 3.396

3.  Stabilization of p53 in influenza A virus-infected cells is associated with compromised MDM2-mediated ubiquitination of p53.

Authors:  Xiaodu Wang; Xufang Deng; Wenjun Yan; Zixiang Zhu; Yang Shen; Yafeng Qiu; Zixue Shi; Donghua Shao; Jianchao Wei; Xianzhu Xia; Zhiyong Ma
Journal:  J Biol Chem       Date:  2012-04-03       Impact factor: 5.157

4.  Influenza A virus replication induces cell cycle arrest in G0/G1 phase.

Authors:  Yuan He; Ke Xu; Bjoern Keiner; Jianfang Zhou; Volker Czudai; Tianxian Li; Ze Chen; Jinhua Liu; Hans-Dieter Klenk; Yue Long Shu; Bing Sun
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

5.  Effects of NS1 variants of H5N1 influenza virus on interferon induction, TNFalpha response and p53 activity.

Authors:  Weizhong Li; Gefei Wang; Heng Zhang; Gang Xin; Dangui Zhang; Jun Zeng; Xiaoxuan Chen; Yanxuan Xu; Youhong Cui; Kangsheng Li
Journal:  Cell Mol Immunol       Date:  2010-03-15       Impact factor: 11.530

6.  Dual Role of p53 in Innate Antiviral Immunity.

Authors:  Carmen Rivas; Stuart A Aaronson; Cesar Munoz-Fontela
Journal:  Viruses       Date:  2010-01-22       Impact factor: 5.818

7.  Cellular transcriptional profiling in human lung epithelial cells infected by different subtypes of influenza A viruses reveals an overall down-regulation of the host p53 pathway.

Authors:  Olivier Terrier; Laurence Josset; Julien Textoris; Virginie Marcel; Gaëlle Cartet; Olivier Ferraris; Catherine N'guyen; Bruno Lina; Jean-Jacques Diaz; Jean-Christophe Bourdon; Manuel Rosa-Calatrava
Journal:  Virol J       Date:  2011-06-08       Impact factor: 4.099

8.  Rapid death of duck cells infected with influenza: a potential mechanism for host resistance to H5N1.

Authors:  Suresh V Kuchipudi; Stephen P Dunham; Rahul Nelli; Gavin A White; Vivien J Coward; Marek J Slomka; Ian H Brown; Kin Chow Chang
Journal:  Immunol Cell Biol       Date:  2011-03-22       Impact factor: 5.126

9.  New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy.

Authors:  Gang Guo; Yan Cui
Journal:  J Immunother Cancer       Date:  2015-03-24       Impact factor: 13.751

Review 10.  Macrophages, inflammation, and tumor suppressors: ARF, a new player in the game.

Authors:  Paqui G Través; Alfonso Luque; Sonsoles Hortelano
Journal:  Mediators Inflamm       Date:  2012-12-18       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.